Modified Bee Venom Peptide Shows Promise for Treating Severe Acute Pancreatitis
HMLT, a histidine-modified melittin derivative, treats severe acute pancreatitis by restoring oxidative balance and macrophage metabolism with significantly less toxicity than natural bee venom peptide.
Quick Facts
What This Study Found
HMLT, a histidine-substituted melittin derivative, ameliorates SAP by restoring oxidative homeostasis and macrophage metabolism with significantly reduced cytotoxicity versus native melittin.
Key Numbers
How They Did This
Peptide design with histidine substitutions; cytotoxicity comparison; SAP models evaluating oxidative stress, macrophage metabolism, and anti-inflammatory efficacy.
Why This Research Matters
Severe acute pancreatitis kills 20-30% of patients and has no specific treatment. A detoxified version of a potent natural anti-inflammatory peptide could become the first targeted therapy.
The Bigger Picture
This demonstrates how rational peptide engineering can tame toxic natural products into potential medicines — taking evolution's powerful molecular weapons and removing their destructive side effects.
What This Study Doesn't Tell Us
Preclinical study; SAP models may not fully replicate human disease complexity; optimal dosing and route for human use not established.
Questions This Raises
- ?Could HMLT be administered intravenously during acute pancreatitis attacks in humans?
- ?Does the histidine modification affect the peptide's mechanism or just reduce toxicity?
Trust & Context
- Key Stat:
- Reduced toxicity, maintained efficacy Histidine-modified melittin retains anti-inflammatory power with lower cytotoxicity
- Evidence Grade:
- Preclinical study with rational drug design — strong proof of concept but no human data.
- Study Age:
- Published in 2026, advancing venom-derived peptide therapeutics for critical illness.
- Original Title:
- A Melittin-Derived Lead Compound Ameliorates Severe Acute Pancreatitis by Restoring Oxidative Homeostasis and Macrophage Metabolism.
- Published In:
- Inflammation, 49(1), 59 (2026)
- Authors:
- Chen, Xiaolong, Chen, Ya(2), Mao, Yunyun(2), Chen, Xinxin, Zhou, Yilin, Tu, Jianfeng
- Database ID:
- RPEP-15002
Evidence Hierarchy
Frequently Asked Questions
How can bee venom help with pancreatitis?
Melittin from bee venom has powerful anti-inflammatory effects, but it also kills healthy cells. By modifying the peptide with histidine amino acids, researchers created a version (HMLT) that keeps the healing properties while reducing the toxic ones.
What is severe acute pancreatitis?
SAP is a life-threatening inflammation of the pancreas that can lead to organ failure and death in 20-30% of cases. Currently there is no specific drug treatment — only supportive care.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-15002APA
Chen, Xiaolong; Chen, Ya; Mao, Yunyun; Chen, Xinxin; Zhou, Yilin; Tu, Jianfeng. (2026). A Melittin-Derived Lead Compound Ameliorates Severe Acute Pancreatitis by Restoring Oxidative Homeostasis and Macrophage Metabolism.. Inflammation, 49(1), 59. https://doi.org/10.1007/s10753-025-02444-9
MLA
Chen, Xiaolong, et al. "A Melittin-Derived Lead Compound Ameliorates Severe Acute Pancreatitis by Restoring Oxidative Homeostasis and Macrophage Metabolism.." Inflammation, 2026. https://doi.org/10.1007/s10753-025-02444-9
RethinkPeptides
RethinkPeptides Research Database. "A Melittin-Derived Lead Compound Ameliorates Severe Acute Pa..." RPEP-15002. Retrieved from https://rethinkpeptides.com/research/chen-2026-a-melittinderived-lead-compound
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.